Sentence examples for risk reduction caused from inspiring English sources

31 In ARISTOTLE, apixaban was superior to warfarin for the prevention of SSE risk reduction, caused significantly fewer MB events than warfarin, and conferred a mortality benefit over warfarin.

Also, it is conceivable that prior adjustment for more sophisticated indicators of obesity and body fat distribution could have diminished the risk reduction caused by the addition of markers of inflammation.

If short-term users (or low cumulative users) are used as the referent exposure group, the more pronounced risk reduction in this group caused by prodromal symptoms would bias relative risks for long-term users (or high cumulative users) upward.

This indicates that people with a muscular strength level equal to or higher than the population average have the same 20% risk reduction in all cause mortality, suggesting the need to target those with very low strength.

We have previously described a 50% relative risk reduction in all cause mortality pursuant to the establishment of an acute medical admission unit [ 2].

Further variables with sizable effects on the ICER include the risk reduction for all-cause mortality (in the worst case, a zero risk reduction on mortality was considered for systematic CRT optimization) and for HF hospitalization ascribed to the SO group.

Assuming that TXA is administered within three hours (because after this time it is unlikely to be effective), the risk of death in the first year after trauma in the intervention group was calculated by multiplying the baseline cumulative hazard of the placebo group by the relative risk reduction of all cause mortality estimated in the CRASH-2 trial (RR = 0.87, 95% CI 0.81 to 0.95) [2].

A borderline significant risk reduction of all-cause mortality was also shown compared with other OHA in monotherapy.

Our findings demonstrate a substantial risk reduction in all-cause mortality and breast cancer-specific mortality when aspirin is taken following a diagnosis of breast cancer.

6 The absolute risk reduction in all-cause mortality in the group scheduled for non-invasive management was 1.7% compared with 1.3% in the overall PLATO sample.

However, in the subgroup of nebivolol recipients from SENIORS aged < 75.2 years who had an LVEF ≤ 35%, the risk reduction for all-cause mortality was 38%.